Search

Your search keyword '"Le Calloch, R."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Le Calloch, R." Remove constraint Author: "Le Calloch, R."
42 results on '"Le Calloch, R."'

Search Results

2. P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL-LIFE EXPERIENCE OF EMMY

8. Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis

12. Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease

13. Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR).

17. Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.

18. [Nurturing and growing a community of department heads: Act 2 in haematology].

19. Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.

20. Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).

21. Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.

22. Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma.

23. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.

24. Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.

25. Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.

27. Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma.

28. Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.

29. Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older.

30. Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.

31. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

32. Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature.

33. Lymphomas with kidney involvement: the French multicenter retrospective LyKID study.

34. Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis.

35. Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).

36. Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase.

37. Immune-checkpoint inhibitors to treat cancers in specific immunocompromised populations: a critical review.

38. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.

39. Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.

40. Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).

42. Fungal arthritis of the hip in patient with aplastic anaemia.

Catalog

Books, media, physical & digital resources